Drug adverse event reports (FAERS)
Reports of adverse events and medication errors sent to FDA for drugs and therapeutic biologics. 20,692,690 records; openFDA updated it 2026-10-05. About this dataset
Newest records
- DRUG INEFFECTIVE1,299,281
- OFF LABEL USE856,381
- DEATH849,878
- NAUSEA778,547
- FATIGUE766,581
- DIARRHOEA634,725
- HEADACHE617,851
- PAIN607,165
- Resorption bone increased, Nerve injury, Eye injury
Drugs: KISUNLA
- Illness
Drugs: ZEPBOUND
- Off label use, Tendonitis
Drugs: MOUNJARO
- Death
Drugs: DURVALUMAB
- Device deployment issue, Product dose omission issue
Drugs: SIMPONI
- Incorrect dose administered
Drugs: DUPIXENT
- Idiopathic urticaria
Drugs: DUPIXENT
- Drug ineffective
Drugs: DUPIXENT
- Dyskinesia
Drugs: DUPIXENT, ABILIFY MAINTENA, AUSTEDO +1
- Maternal exposure during pregnancy
Drugs: DUPIXENT
- Dry skin, Pruritus, Skin exfoliation
Drugs: DUPIXENT
- Off label use
Drugs: DUPIXENT
- Drug ineffective, Quality of life decreased
Drugs: DUPIXENT
- Placental disorder, Preterm premature rupture of membranes, Oligohydramnios +2
Drugs: DUPIXENT, SYMBICORT
- Accidental exposure to product, Exposure via skin contact
Drugs: DUPIXENT
- Lip and/or oral cavity cancer
Drugs: RINVOQ
- Death
Drugs: RINVOQ
- Cellulitis, Pyrexia, Vomiting +1
Drugs: IMBRUVICA, ERYTHROPOIETIN, LOSARTAN
Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.
How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.
